CD99 overexpression also correlates with tumor hypoxia, angiogenesis, epithelial–mesenchymal transition, metabolic reprogramming, and an M2 macrophage-dominated immunosuppressive microenvironment, aiding high-CD99 tumor progression. This evidence concerns the gene CD99 and neoplasm.